-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A new study by Neurology and eight international epilepsy collaborating centers has developed a simple web application that clinicians can use to predict which patients will not benefit from invasive diagnostic tests and prevent unnecessary intrusions Sexual procedures save time for patients and clinical teams and release overburdened health resources
Surgery is the only option to treat seizures in hospitalized patients with drug-resistant epilepsy
SEEG is an invasive surgery that requires hospitalization for 1-2 weeks.
The research team followed 128 patients with SEEG and analyzed their demographic, clinical, EEG, neuroimaging, and neuropsychological data
"Many epilepsy centers face a challenging decision whether patients should determine the focal seizure area through implantation," said Dr.
This research was published in the Journal of the American Medical Association on December 6, 2021, and was funded by the Montreal Neurological Institute and the Research Foundation (Fonds de Recherche du Québec- Santé) and the Austrian branch of the International Anti-Epilepsy League
Article title
Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography
